204 related articles for article (PubMed ID: 16284340)
1. Microarray gene expression data with linked survival phenotypes: diffuse large-B-cell lymphoma revisited.
Segal MR
Biostatistics; 2006 Apr; 7(2):268-85. PubMed ID: 16284340
[TBL] [Abstract][Full Text] [Related]
2. Penalized Cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression data.
Gui J; Li H
Bioinformatics; 2005 Jul; 21(13):3001-8. PubMed ID: 15814556
[TBL] [Abstract][Full Text] [Related]
3. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma.
Wright G; Tan B; Rosenwald A; Hurt EH; Wiestner A; Staudt LM
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9991-6. PubMed ID: 12900505
[TBL] [Abstract][Full Text] [Related]
4. Partial Cox regression analysis for high-dimensional microarray gene expression data.
Li H; Gui J
Bioinformatics; 2004 Aug; 20 Suppl 1():i208-15. PubMed ID: 15262801
[TBL] [Abstract][Full Text] [Related]
5. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes.
Lossos IS; Czerwinski DK; Alizadeh AA; Wechser MA; Tibshirani R; Botstein D; Levy R
N Engl J Med; 2004 Apr; 350(18):1828-37. PubMed ID: 15115829
[TBL] [Abstract][Full Text] [Related]
6. Assessment of survival prediction models based on microarray data.
Schumacher M; Binder H; Gerds T
Bioinformatics; 2007 Jul; 23(14):1768-74. PubMed ID: 17485430
[TBL] [Abstract][Full Text] [Related]
7. Randomized maps for assessing the reliability of patients clusters in DNA microarray data analyses.
Bertoni A; Valentini G
Artif Intell Med; 2006 Jun; 37(2):85-109. PubMed ID: 16720093
[TBL] [Abstract][Full Text] [Related]
8. Expression profiling analysis of the CD5+ diffuse large B-cell lymphoma subgroup: development of a CD5 signature.
Suguro M; Tagawa H; Kagami Y; Okamoto M; Ohshima K; Shiku H; Morishima Y; Nakamura S; Seto M
Cancer Sci; 2006 Sep; 97(9):868-74. PubMed ID: 16856881
[TBL] [Abstract][Full Text] [Related]
9. Molecular diagnosis of lymphoma: outcome prediction by gene expression profiling in diffuse large B-cell lymphoma.
Last K; Debarnardi S; Lister TA
Methods Mol Med; 2005; 115():15-63. PubMed ID: 15998962
[TBL] [Abstract][Full Text] [Related]
10. Kernel Cox regression models for linking gene expression profiles to censored survival data.
Li H; Luan Y
Pac Symp Biocomput; 2003; ():65-76. PubMed ID: 12603018
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
Tagawa H
Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
[TBL] [Abstract][Full Text] [Related]
12. Kernel mixture survival models for identifying cancer subtypes, predicting patient's cancer types and survival probabilities.
Ando T; Imoto S; Miyano S
Genome Inform; 2004; 15(2):201-10. PubMed ID: 15706506
[TBL] [Abstract][Full Text] [Related]
13. Profiling of apoptosis genes allows for clinical stratification of primary nodal diffuse large B-cell lymphomas.
Muris JJ; Ylstra B; Cillessen SA; Ossenkoppele GJ; Kluin-Nelemans JC; Eijk PP; Nota B; Tijssen M; de Boer WP; van de Wiel M; van den Ijssel PR; Jansen P; de Bruin PC; van Krieken JH; Meijer GA; Meijer CJ; Oudejans JJ
Br J Haematol; 2007 Jan; 136(1):38-47. PubMed ID: 17062006
[TBL] [Abstract][Full Text] [Related]
14. Dimension reduction methods for microarrays with application to censored survival data.
Li L; Li H
Bioinformatics; 2004 Dec; 20(18):3406-12. PubMed ID: 15256406
[TBL] [Abstract][Full Text] [Related]
15. Data pattern analysis for the individualised pretherapeutic identification of high-risk diffuse large B-cell lymphoma (DLBCL) patients by cytomics.
Valet GK; Hoeffkes HG
Cytometry A; 2004 Jun; 59(2):232-6. PubMed ID: 15170602
[TBL] [Abstract][Full Text] [Related]
16. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma.
Sagaert X; de Paepe P; Libbrecht L; Vanhentenrijk V; Verhoef G; Thomas J; Wlodarska I; De Wolf-Peeters C
J Clin Oncol; 2006 Jun; 24(16):2490-7. PubMed ID: 16636337
[TBL] [Abstract][Full Text] [Related]
17. The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma.
Goy A; Stewart J; Barkoh BA; Remache YK; Katz R; Sneige N; Gilles F
Cancer; 2006 Feb; 108(1):10-20. PubMed ID: 16329118
[TBL] [Abstract][Full Text] [Related]
18. National Oncology Forum: perspectives for the year 2000.
DeVita VT; Bleickardt EW
Cancer J; 2001; 7 Suppl 1():S2-13. PubMed ID: 11504281
[TBL] [Abstract][Full Text] [Related]
19. Diffuse large B-cell lymphoma with overexpression of cyclin e substantiates poor standard treatment response and inferior outcome.
Tzankov A; Gschwendtner A; Augustin F; Fiegl M; Obermann EC; Dirnhofer S; Went P
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2125-32. PubMed ID: 16609025
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic significance of gene expression profiling in lymphomas.
Leich E; Hartmann EM; Burek C; Ott G; Rosenwald A
APMIS; 2007 Oct; 115(10):1135-46. PubMed ID: 18042147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]